
Article 1 
Annexes I and II to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.
Article 2 
This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.
It shall apply from the sixtieth day following its publication.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 10 June 2004.
For the Commission
Erkki LIIKANEN
Member of the Commission
ANNEX
A.  1.  1.2.  1.2.4. 

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues
‘Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine 100 μg/kg Fat
Porcine 3 000 μg/kg Liver
3 000 μg/kg Kidney
100 μg/kg Skin + fat
3 000 μg/kg Liver
3 000 μg/kg Kidney


B.  2. 

Pharmacologically active substance(s) Animal species
‘Diclazuril all ruminantsPorcine


